2039 Phase IB/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer. (September 2015) - Wang, A.; Sanoff, H.; McRee, A.; O'Neil, B.; Calvo, B.; Hennessy, M.; Murphy, C.; Tynan, M.; Blackstock, W.; Garmey, E.; Tepper, J.